Problem statement: Answer the multiple-choice question.
Question: Which drug exhibits a 3.826\% human ether-à-go-go related gene (hERG) inhibition at 1uM?
Constraint: You must select none, one or more options from a or b without using any additional words.
Options:
a: O=C(Nc1cccc(Cl)c1)c1ccc(=O)[nH]n1
b: CC1(C)CC(NC(=O)C23CCC(C)(/C(=N/O)C2)C3(C)C)CC(C)(C)N1
Answer: b. CC1(C)CC(NC(=O)C23CCC(C)(/C(=N/O)C2)C3(C)C)CC(C)(C)N1
{#Task|Problem statement!}: Answer the {#multiple choice|multiple-choice|MCQ!} question.
{#Question|Query!}: Which {#compound|drug!} {#has|exhibits!} a {herg_central_at_1uM#}{herg_central_at_1uM__units} {herg_central_at_1uM__names__noun}?
Constraint: You must select none, one or more options from {%multiple_choice_enum%2-5%aA1} without using any {#other|additional!} words.
Options:
{SMILES%herg_central_at_1uM%}
Answer: {%multiple_choice_result}. {SMILES#}
CC1(C)CC(NC(=O)C23CCC(C)(/C(=N/O)C2)C3(C)C)CC(C)(C)N1
CC1(C)CC(NC(=O)C23CCC(C)(/C(=N/O)C2)C3(C)C)CC(C)(C)N1
(3E)-3-hydroxyimino-4,7,7-trimethyl-N-(2,2,6,6-tetramethylpiperidin-4-yl)bicyclo[2.2.1]heptane-1-carboxamide